Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Expression patterns of PAX5, c-Met, and paxillin in neuroendocrine tumors of the lung.

Song J, Li M, Tretiakova M, Salgia R, Cagle PT, Husain AN.

Arch Pathol Lab Med. 2010 Nov;134(11):1702-5. doi: 10.1043/2009-0664-OAR1.1.

2.

Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.

Swarts DR, Ramaekers FC, Speel EJ.

Biochim Biophys Acta. 2012 Dec;1826(2):255-71. doi: 10.1016/j.bbcan.2012.05.001. Epub 2012 May 10. Review.

PMID:
22579738
3.

Pathology and diagnosis of neuroendocrine tumors: lung neuroendocrine.

Travis WD.

Thorac Surg Clin. 2014 Aug;24(3):257-66. doi: 10.1016/j.thorsurg.2014.04.001. Review.

PMID:
25065926
4.

[Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].

Langfort R, RudziƄski P, Burakowska B.

Pneumonol Alergol Pol. 2010;78(1):33-46. Review. Polish.

5.

[Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].

Schnabel PA, Junker K.

Pathologe. 2015 May;36(3):283-92. doi: 10.1007/s00292-015-0030-2. Review. German.

PMID:
25956813
6.

Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer.

Findeis-Hosey JJ, Xu H.

Biotech Histochem. 2012 Jan;87(1):24-9. doi: 10.3109/10520295.2011.591831. Epub 2011 Aug 15. Review.

PMID:
21838610
7.

Advances in neuroendocrine lung tumors.

Travis WD.

Ann Oncol. 2010 Oct;21 Suppl 7:vii65-71. doi: 10.1093/annonc/mdq380. Review.

PMID:
20943645
8.

Biology and novel therapeutics for neuroendocrine tumors of the lung.

Jafri N, Salgia R.

J Biol Regul Homeost Agents. 2004 Jul-Dec;18(3-4):275-90. Review.

PMID:
15786694
9.

[Thoracic neuroendocrine tumors].

Brambilla E, Lantuejoul S.

Ann Pathol. 2005 Dec;25(6):529-44. Review. French.

PMID:
16735977
10.

What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?

Pelosi G, Fabbri A, Cossa M, Sonzogni A, Valeri B, Righi L, Papotti M.

Semin Diagn Pathol. 2015 Nov;32(6):469-79. doi: 10.1053/j.semdp.2015.10.009. Epub 2015 Oct 22. Review.

11.

Systemic therapy for pulmonary carcinoids.

Marquez-Medina D, Popat S.

Lung Cancer. 2015 Nov;90(2):139-47. doi: 10.1016/j.lungcan.2015.08.018. Epub 2015 Sep 12. Review.

PMID:
26371699
12.
13.

Pulmonary Neuroendocrine Tumors: Part I. Spectrum and Characteristics of Tumors.

Dincer HE, Podgaetz E, Andrade RS.

J Bronchology Interv Pulmonol. 2015 Jul;22(3):267-73. doi: 10.1097/LBR.0000000000000157. Review.

PMID:
26165900
14.

Diagnostic uses of Pax5 immunohistochemistry.

Feldman AL, Dogan A.

Adv Anat Pathol. 2007 Sep;14(5):323-34. Review.

PMID:
17717432
15.

Neuroendocrine tumors of the lung: recent developments in histopathology.

Flieder DB.

Curr Opin Pulm Med. 2002 Jul;8(4):275-80. Review.

PMID:
12055389
16.

Carcinomas of the lung with neuroendocrine differentiation.

Carter D, Yesner R.

Semin Diagn Pathol. 1985 Nov;2(4):235-54. Review.

PMID:
3039628
17.

Neuroendocrine Tumors of the Lung: Current Challenges and Advances in the Diagnosis and Management of Well-Differentiated Disease.

Hendifar AE, Marchevsky AM, Tuli R.

J Thorac Oncol. 2017 Mar;12(3):425-436. doi: 10.1016/j.jtho.2016.11.2222. Epub 2016 Nov 24. Review.

18.

Notch Signaling in Neuroendocrine Tumors.

Crabtree JS, Singleton CS, Miele L.

Front Oncol. 2016 Apr 14;6:94. doi: 10.3389/fonc.2016.00094. eCollection 2016. Review.

Supplemental Content

Support Center